Skip to content
Screener

EV / EBITDA at other companies

Abbott logo
AbbottABT
17.2×-6.0×
Danaher logo
DanaherDHR
20.7×-2.4×
OraSure Technologies logo
OraSure TechnologiesOSUR
5,466.1×
Revvity logo
RevvityRVTY
16.7×-2.2×
Opko Health logo
Opko HealthOPK
28.5×
Quest Diagnostics logo
Quest DiagnosticsDGX
13.2×+0.3×

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$1.14B-29.9%
Enterprise value$4.11B-14.6%
P/S0.4×-0.2×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Calculated from QuidelOrtho Corporation’s reported figures.

Based on the most recent quarter.

The source filing: QuidelOrtho Corporation’s 10-Q, filed August 6, 2025. Open the filing →

Filed
Aug 6, 2025
Fiscal quarter
Q2 FY2025
Calendar quarter
Q3 2025
Accession
0001906324-25-000151

FAQ

What is QuidelOrtho Corporation's EV / EBITDA?
QuidelOrtho Corporation (QDEL) reported EV / EBITDA of 23× in Q2 2025.
What is the long-term trend for QuidelOrtho Corporation's EV / EBITDA?
Over 2 years (2021 to 2023), QuidelOrtho Corporation's EV / EBITDA has grown at a 78.4% compound annual growth rate (CAGR), from 3.8× to 12.1×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.

Ask your AI about QuidelOrtho Corporation's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude